DuPont/BioLeap agchem discovery deal
DuPont has entered into a research collaboration with US drug discovery company BioLeap (Pennington, New Jersey) to use BioLeap’s molecular design technology to discover new crop protection compounds. BioLeap will use its proprietary technology in computational fragment-based design to identify compounds aimed at biological targets of interest to DuPont. The companies will jointly select compounds for synthesis and further evaluation by DuPont. The terms of the deal, including discovery milestones, have not been disclosed. BioLeap formed a similar collaboration with Syngenta earlier this year ( Agrow No 614, p 3).